282 related articles for article (PubMed ID: 20228063)
1. A novel C53/LZAP-interacting protein regulates stability of C53/LZAP and DDRGK domain-containing Protein 1 (DDRGK1) and modulates NF-kappaB signaling.
Wu J; Lei G; Mei M; Tang Y; Li H
J Biol Chem; 2010 May; 285(20):15126-15136. PubMed ID: 20228063
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor protein C53 antagonizes checkpoint kinases to promote cyclin-dependent kinase 1 activation.
Jiang H; Wu J; He C; Yang W; Li H
Cell Res; 2009 Apr; 19(4):458-68. PubMed ID: 19223857
[TBL] [Abstract][Full Text] [Related]
3. Caspase-mediated cleavage of C53/LZAP protein causes abnormal microtubule bundling and rupture of the nuclear envelope.
Wu J; Jiang H; Luo S; Zhang M; Zhang Y; Sun F; Huang S; Li H
Cell Res; 2013 May; 23(5):691-704. PubMed ID: 23478299
[TBL] [Abstract][Full Text] [Related]
4. A novel LZAP-binding protein, NLBP, inhibits cell invasion.
Kwon J; Cho HJ; Han SH; No JG; Kwon JY; Kim H
J Biol Chem; 2010 Apr; 285(16):12232-40. PubMed ID: 20164180
[TBL] [Abstract][Full Text] [Related]
5. LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB.
Wang J; An H; Mayo MW; Baldwin AS; Yarbrough WG
Cancer Cell; 2007 Sep; 12(3):239-51. PubMed ID: 17785205
[TBL] [Abstract][Full Text] [Related]
6. LZAP inhibits p38 MAPK (p38) phosphorylation and activity by facilitating p38 association with the wild-type p53 induced phosphatase 1 (WIP1).
An H; Lu X; Liu D; Yarbrough WG
PLoS One; 2011 Jan; 6(1):e16427. PubMed ID: 21283629
[TBL] [Abstract][Full Text] [Related]
7. Cdk5 activator-binding protein C53 regulates apoptosis induced by genotoxic stress via modulating the G2/M DNA damage checkpoint.
Jiang H; Luo S; Li H
J Biol Chem; 2005 May; 280(21):20651-9. PubMed ID: 15790566
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin fold modifier 1 activates NF-κB pathway by down-regulating LZAP expression in the macrophage of diabetic mouse model.
Hu X; Zhang H; Song Y; Zhuang L; Yang Q; Pan M; Chen F
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31829413
[TBL] [Abstract][Full Text] [Related]
9. DDRGK1 regulates NF-κB activity by modulating IκBα stability.
Xi P; Ding D; Zhou J; Wang M; Cong YS
PLoS One; 2013; 8(5):e64231. PubMed ID: 23675531
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of the Ufm1 conjugation system in response to disturbance of the endoplasmic reticulum homeostasis and inhibition of vesicle trafficking.
Zhang Y; Zhang M; Wu J; Lei G; Li H
PLoS One; 2012; 7(11):e48587. PubMed ID: 23152784
[TBL] [Abstract][Full Text] [Related]
11. RCAD/BiP pathway is necessary for the proper synthesis of digestive enzymes and secretory function of the exocrine pancreas.
Miller C; Cai Y; Patton T; Graves SH; Li H; Sabbatini ME
Am J Physiol Gastrointest Liver Physiol; 2017 Mar; 312(3):G314-G326. PubMed ID: 28104585
[TBL] [Abstract][Full Text] [Related]
12. LZAP is a novel Wip1 binding partner and positive regulator of its phosphatase activity in vitro.
Wamsley JJ; Issaeva N; An H; Lu X; Donehower LA; Yarbrough WG
Cell Cycle; 2017 Jan; 16(2):213-223. PubMed ID: 28027003
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressor Lzap regulates cell cycle progression, doming, and zebrafish epiboly.
Liu D; Wang WD; Melville DB; Cha YI; Yin Z; Issaeva N; Knapik EW; Yarbrough WG
Dev Dyn; 2011 Jun; 240(6):1613-25. PubMed ID: 21523853
[TBL] [Abstract][Full Text] [Related]
14. Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma.
Zhao JJ; Pan K; Li JJ; Chen YB; Chen JG; Lv L; Wang DD; Pan QZ; Chen MS; Xia JC
PLoS One; 2011; 6(10):e26608. PubMed ID: 22028922
[TBL] [Abstract][Full Text] [Related]
15. Tumor Suppressor Lzap Suppresses Wnt/β-Catenin Signaling to Promote Zebrafish Embryonic Ventral Cell Fates via the Suppression of Inhibitory Phosphorylation of Glycogen Synthase Kinase 3.
Lin KY; Kao SH; Lai CM; Chen CT; Wu CY; Hsu HJ; Wang WD
J Biol Chem; 2015 Dec; 290(50):29808-19. PubMed ID: 26475862
[TBL] [Abstract][Full Text] [Related]
16. DDRGK1 Enhances Osteosarcoma Chemoresistance via Inhibiting KEAP1-Mediated NRF2 Ubiquitination.
Wang X; Zhou T; Yang X; Cao X; Jin G; Zhang P; Guo J; Rong K; Li B; Hu Y; Liu K; Ma P; Qin A; Zhao J
Adv Sci (Weinh); 2023 May; 10(14):e2204438. PubMed ID: 36965071
[TBL] [Abstract][Full Text] [Related]
17. CDK5RAP3 is a novel repressor of p14ARF in hepatocellular carcinoma cells.
Mak GW; Lai WL; Zhou Y; Li M; Ng IO; Ching YP
PLoS One; 2012; 7(7):e42210. PubMed ID: 22860085
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of a novel activator of PAK4, the CDK5 kinase-associated protein CDK5RAP3, promotes hepatocellular carcinoma metastasis.
Mak GW; Chan MM; Leong VY; Lee JM; Yau TO; Ng IO; Ching YP
Cancer Res; 2011 Apr; 71(8):2949-58. PubMed ID: 21385901
[TBL] [Abstract][Full Text] [Related]
19. RBCK1 negatively regulates tumor necrosis factor- and interleukin-1-triggered NF-kappaB activation by targeting TAB2/3 for degradation.
Tian Y; Zhang Y; Zhong B; Wang YY; Diao FC; Wang RP; Zhang M; Chen DY; Zhai ZH; Shu HB
J Biol Chem; 2007 Jun; 282(23):16776-82. PubMed ID: 17449468
[TBL] [Abstract][Full Text] [Related]
20. The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB signalling.
Shembade N; Parvatiyar K; Harhaj NS; Harhaj EW
EMBO J; 2009 Mar; 28(5):513-22. PubMed ID: 19131965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
